What? When? Why?
Latest Happenings in Business World
01
Oct-2019
Global Antibiotics Market Size to Grow USD 57.4 Billion By 2026
Global Antibiotics Market Size, Share, Trends, COVID-19 Impact, and Growth Analysis Report – Segmented By Action Mechanism, Drug Class and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Industry Forecast (2021 to 2026)
Global Antibiotics Market Size (2021 to 2026)
The size of the global antibiotics market is predicted to be growing at a CAGR of 4% from 2021 to 2026 and worth USD 57.4 billion by 2026.
MARKET DYNAMICS:
The proliferation of contagious diseases, bacterial infections, and the rising consumption of antibiotics is driving the market growth. Also, an increase in antibiotic resistance infections due to antibiotic abuse or overuse is predicted to alter prescription trends towards new antibacterial therapies. In addition, developments in generic drugs and the expanding vulnerable aging population are also contributing to the overall growth of this market.
Over the forecast period, the market is likely to be driven by pharmaceutical firms' increasing efforts to develop innovative treatments to treat infectious diseases. Furthermore, due to the extremely growing incidence of infectious diseases, the need for antibiotics is rising. In addition, infectious illnesses such as lower respiratory infections, pneumonia, malaria, and TB are also fuelling the market growth.
The rising demand for animal-derived food items, the rising incidence of zoonotic diseases, and the adoption of laws to limit the spread of animal diseases are all contributing to market growth. Antibiotic-resistant infections impact more than 2.8 million people in the United States, according to the CDC. In developed countries, infections such as Enterobacteriaceae, Pseudomonas aeruginosa, and K. pneumonia have a high resistance rate of 40 percent on average.
The market is anticipated to expand further as animal healthcare spending rises and demand for pet insurance increases. In the future, untapped growing countries such as China, India, and Brazil and an increase in the overall companion animal population are projected to provide substantial growth opportunities for market players. In addition, the rising disease burden is pressuring the government and non-government organizations to engage in R&D projects, accelerate the development of novel antibiotics, and support regulatory policies to accelerate the approval process and research funding. For example, in collaboration with the government, BARDA has provided funding to several firms to develop novel antimicrobial therapies.
Pharmaceutical firms are collaborating on the development of novel medicines to lower the cost of drug development. For example, in July 2019, Nosopharm announced a partnership with Evotec AG to develop NOSO-502. It's a first-in-class new antibiotic for bacterial infections by Enterobacteriaceae.
Avail sample market brochure of the report @ https://www.marketdataforecast.com/market-reports/antibiotics-market/request-sample
KEY MARKET INSIGHTS:
- Based on the action mechanism, the Cell Wall Synthesis Inhibitors segment dominated the market. The drugs prevent bacteria from producing peptidoglycan, a chemical found in the cell wall that provides it the power to live in the human body. These medicines, among others, are anticipated to increase at the highest rate. Many antibiotics operate by preventing DNA synthesis as well as the conversion of DNA to RNA. It is a significant finding since it can help cure many natural-born diseases that we have been unable to treat. These medicines account for the second-largest proportion of the market.
- Based on drug class, the other antibiotics market accounted for the largest share over the forecast period. This segment focuses on the development of monoclonal antibodies for those who have developed antibiotic resistance. Penicillin is the oldest medicine ever discovered, and it still has a significant market share.
- Geographically, the APAC antibiotics market dominated the global market and accounted for a significant share of 45.2% in 2020. The market growth in the region is attributed to the prevalence of contagious diseases, rising consumption of antibiotics and the presence of developing countries such as China, India, and Japan are expanding the market growth. The North American antibiotics market accounted for the second most share in the global antibiotics market due to technological advancements in the health sector, favorable reimbursement policies, and growing healthcare expenditure. Infection control initiatives and encouraging R&D activities of new treatments to control infectious diseases are among the measures taken by the US government. The European antibiotics market is projected to have the highest share in the market during the forecast period. Prevalence of infectious and chronic diseases, availability of a substantial number of pharmaceutical manufacturers, and many players have been focusing on new drug development and clinical trials. The countries such as Germany, UK, France, Spain, and Italy contribute to the European regional market growth.
- Johnson and Johnson, Novartis AG, Abbott Inc., Glaxo SmithKline, Pfizer PLC, Merck & Co. Inc., Bayer AG, Sanofi SA, and F. Hoffmann-La Roche AG are some of the promising companies in the global antibiotics market.
The report can be customized as per requirements; ask for it @ https://www.marketdataforecast.com/market-reports/antibiotics-market/customization
MARKET SEGMENTATION:
By Action Mechanism:
- Cell Wall Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Synthesis Inhibitors
- Folic Acid Synthesis Inhibitors
By Drug Class:
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa
KEY MARKET PLAYERS PROFILED IN THIS REPORT:
- GlaxoSmithKline
- Johnson and Johnson
- Pfizer PLC
- Bayer AG
- Novartis AG
- Abbott Inc.
- Merck & Co. Inc.
- Sanofi SA
- F. Hoffmann-La Roche AG
WRITTEN BY: Karthik Thelakula
Karthik Thelakula is a Content Writer in Market Data Forecast, one of the world’s leading research and consulting for various business domains, individuals and corporate clients
CATEGORY
RECENT POST
CLIENTS
.webp)
